+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Dysmenorrhea Market Report and Forecast 2024-2032 - Product Thumbnail Image

Dysmenorrhea Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
From
Pancreatic Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 4317 Pages
  • Global
From
Kidney Disease (Nephropathy) - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Kidney Disease (Nephropathy) - Global Clinical Trials Review, 2025

  • Clinical Trials
  • May 2025
  • 5100 Pages
  • Global
From
Thrombocytopenia - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Thrombocytopenia - Global Clinical Trials Review, 2025

  • Clinical Trials
  • April 2025
  • 915 Pages
  • Global
From
PRMT5 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

PRMT5 Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Canada Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Canada Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

  • Report
  • September 2022
  • 77 Pages
  • Canada
From
Turkey Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Turkey Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

  • Report
  • September 2022
  • 82 Pages
  • Turkey
From
MCL1 Protein Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

MCL1 Protein Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
Loading Indicator